Artio closes $28M as it scales to save lives; latest funding brings Prairie Village startup’s investments to $74M
June 16, 2022 | Startland News Staff
Another hefty funding round for Artio Medical is expected to launch the startup’s commercial sales team in the U.S. and continue development of its best-in-class product pipeline, said founder Nicholas Franano.
Artio, a medical device company developing innovative products for the peripheral vascular, neurovascular, and cardiology markets, on Thursday announced the closing of $28 million in oversubscribed Series A2 and Series A3 financing, bringing the total amount raised to date to $74 million.
Funds will be used to support U.S. commercialization efforts for the recently cleared Solus Gold Embolization Device and to accelerate the development of Artio’s broad portfolio of products, including expanding the company’s engineering and manufacturing capabilities, Franano said in a press release.
Click here to read more about Artio’s $12 million funding infusion in 2021.
“We would like to thank our existing investors for their continued strong support and also welcome a new group of investors to Artio,” said Joseph McConnell, vice president of finance and business operations at Artio.
“We have the opportunity to do something really special here, to bring a new generation of medical devices to market with the potential to save lives, reduce disability, and improve the quality of life for millions of people,” McConnell continued. “This new capital will help Artio expand our team and scale our operations to deliver on that mission.”
Artio is currently developing ten products for the peripheral vascular market, including the Solus Gold and Solus Flex Embolization Devices for peripheral vessel occlusion and the Amplifi Vein Dilation System which is designed to prepare hemodialysis patients for successful arteriovenous fistula vascular access site creation.
Artio is also currently developing four products for the neurovascular market, including the Endura Embolization System comprising a detachable balloon and coils for the treatment of saccular brain aneurysms.
Click here to learn more about Artio’s portfolio of products.
2022 Startups to Watch
stats here
Related Posts on Startland News
Artist incubator paints scene of blissful collaboration in far-from-lonely West Bottoms space
Vanessa Lacy’s artist incubator eliminates “the lonely artist,” she said, noting her gallery model replaces solitude with creative relationships and a collaborative community. “Artists tend to get very isolated in their studio spaces working on their own; then they have a relationship with a gallery that’s really more of a business relationship,” said Lacy, owner…
Order here: Menufy online restaurant platform delivers results, food from OP startup
Servicing the online orders of more than 300 restaurants in the Kansas City metro, Overland Park-based Menufy is scaling its platform across the U.S., while maintaining a startup mindset, said Ashishh Desai. “Even though now we have over 4,000 restaurants nationwide — every state but Vermont and in 1,200 cities — we still have that…
Take the Kauffman survey: Is KC’s startup culture welcoming and inclusive to all?
Perception shapes reality, said organizers of a survey that seeks greater understanding of Kansas City’s startup culture. The Ewing Marion Kauffman Foundation’s 2018 Entrepreneurship in Kansas City survey checks the pulse of the local entrepreneurial ecosystem by raising specific questions about culture and practice in workplaces across the metro, said John Quinterno and Julie Marks,…
Onward scores $1M grant from Chan Zuckerberg Initiative for payday loan end-run
Everyone needs a financial cushion, said Ronnie Washington — even a fintech startup offering low- to moderate-income workers a path to avoid predatory lending practices, the Onward founder said. A member of KC-based Fountain City Fintech’s inaugural cohort, Onward is one of 10 companies from across the U.S. and Puerto Rico being awarded $1 million…